Hu W - Search Results

1

Increased phosphorylation of myosin light chain prevents in vitro decidualization.

Ihnatovych I, Hu W, Martin JL, Fazleabas AT, de Lanerolle P, Strakova Z. Ihnatovych I, et al. Among authors: hu w. Endocrinology. 2007 Jul;148(7):3176-84. doi: 10.1210/en.2006-1673. Epub 2007 Apr 5. Endocrinology. 2007. PMID: 17412815

2

Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo.

Fazal F, Gu L, Ihnatovych I, Han Y, Hu W, Antic N, Carreira F, Blomquist JF, Hope TJ, Ucker DS, de Lanerolle P. Fazal F, et al. Among authors: hu w. Mol Cell Biol. 2005 Jul;25(14):6259-66. doi: 10.1128/MCB.25.14.6259-6266.2005. Mol Cell Biol. 2005. PMID: 15988034 Free PMC article.

3

Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells.

Gu LZ, Hu WY, Antic N, Mehta R, Turner JR, de Lanerolle P. Gu LZ, et al. Eur J Cancer. 2006 May;42(7):948-57. doi: 10.1016/j.ejca.2005.12.017. Epub 2006 Mar 30. Eur J Cancer. 2006. PMID: 16574402

4

Increased myosin light chain kinase expression in hypertension: Regulation by serum response factor via an insertion mutation in the promoter.

Han YJ, Hu WY, Chernaya O, Antic N, Gu L, Gupta M, Piano M, de Lanerolle P. Han YJ, et al. Mol Biol Cell. 2006 Sep;17(9):4039-50. doi: 10.1091/mbc.e06-04-0353. Epub 2006 Jul 5. Mol Biol Cell. 2006. PMID: 16822834 Free PMC article.

5

Involvement of Ras-regulated myosin light chain phosphorylation in the captopril effects in spontaneously hypertensive rats.

Hu WY, Han YJ, Gu LZ, Piano M, de Lanerolle P. Hu WY, et al. Am J Hypertens. 2007 Jan;20(1):53-61. doi: 10.1016/j.amjhyper.2006.05.024. Am J Hypertens. 2007. PMID: 17198912

6

Regulation of myosin light chain kinase expression by angiotensin II in hypertension.

Han YJ, Hu WY, Piano M, de Lanerolle P. Han YJ, et al. Am J Hypertens. 2008 Aug;21(8):860-5. doi: 10.1038/ajh.2008.199. Epub 2008 May 29. Am J Hypertens. 2008. PMID: 18511912

7

Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells.

Hu WY, Shi GB, Lam HM, Hu DP, Ho SM, Madueke IC, Kajdacsy-Balla A, Prins GS. Hu WY, et al. Endocrinology. 2011 Jun;152(6):2150-63. doi: 10.1210/en.2010-1377. Epub 2011 Mar 22. Endocrinology. 2011. PMID: 21427218 Free PMC article.

8

Tumor stiffness is unrelated to myosin light chain phosphorylation in cancer cells.

Yu HJ, Serebryannyy LA, Fry M, Greene M, Chernaya O, Hu WY, Chew TL, Mahmud N, Kadkol SS, Glover S, Prins G, Strakova Z, de Lanerolle P. Yu HJ, et al. PLoS One. 2013 Nov 4;8(11):e79776. doi: 10.1371/journal.pone.0079776. eCollection 2013. PLoS One. 2013. PMID: 24224004 Free PMC article.

9

Stem Cells as Hormone Targets That Lead to Increased Cancer Susceptibility.

Prins GS, Calderon-Gierszal EL, Hu WY. Prins GS, et al. Endocrinology. 2015 Oct;156(10):3451-7. doi: 10.1210/en.2015-1357. Epub 2015 Aug 4. Endocrinology. 2015. PMID: 26241068 Free PMC article.

10

Estrogen action and prostate cancer.

Nelles JL, Hu WY, Prins GS. Nelles JL, et al. Expert Rev Endocrinol Metab. 2011 May;6(3):437-451. doi: 10.1586/eem.11.20. Expert Rev Endocrinol Metab. 2011. PMID: 21765856 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,197 results

Search Page